← Leaderboards
Jacob V Aranda
Wayne State University
$4,260,210
Attributed
$4,260,210
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,880,807 · 7
By mechanism
U54$5,149,459 · 4
U01$1,424,361 · 1
U10$1,113,272 · 1
R03$193,715 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Anthony Frank Shields$10,178,885
- M Safwan Badr$6,917,228
- Leslie H Lundahl$2,885,183
Others in their field
Top investigators on “Clinical Pharmacology”
- Constance Ann Benson · University Of California, San Diego$243,271,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,494,514
- Daniel R Kuritzkes · Brigham And Women'S Hospital$211,464,839
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$173,041,343
- Garret A Fitzgerald · University Of Pennsylvania$143,674,197
- David Heimbrook · Leidos Biomedical Research, Inc.$131,279,031
Research focus
Clinical PharmacologyMolecularRetinopathy Of PrematurityPediatric PharmacologyChildhoodNeonatalResearch PersonnelEventTranslational ResearchRetinal DiseasesRetinaVascular Endothelial Growth FactorsClinical ResearchDesignOxygenSignal TransductionClinical TrialsHyperoxiaDrug Screening /EvaluationDrug Adverse EffectSafetyPharmaceutical PreparationsPharmacodynamicsChild
Grant awards (29)
Molecular and Clinical Pharmacology of Retinopathy of Prematurity$684,231
U54 · FY2015 · HD · contact PI
Synergistic Pharmacologicjntervention for Prevention of ROP (SPIPROP STUDY)$152,106
U54 · FY2015 · HD · contact PI
ADMINISTRATIVE$117,508
U54 · FY2015 · HD · contact PI
NEONATAL TRANSLATIONAL$38,144
U54 · FY2015 · HD · contact PI
Molecular and Clinical Pharmacology of Retinopathy of Prematurity$648,867
U54 · FY2014 · HD · contact PI
Synergistic Pharmacologicjntervention for Prevention of ROP (SPIPROP STUDY)$147,848
U54 · FY2014 · HD · contact PI
ADMINISTRATIVE$114,218
U54 · FY2014 · HD · contact PI
NEONATAL TRANSLATIONAL$37,075
U54 · FY2014 · HD · contact PI
Molecular and Clinical Pharmacology of Retinopathy of Prematurity$709,379
U54 · FY2013 · HD · contact PI
Synergistic Pharmacologicjntervention for Prevention of ROP (SPIPROP STUDY)$152,106
U54 · FY2013 · HD · contact PI
ADMINISTRATIVE$117,507
U54 · FY2013 · HD · contact PI
NEONATAL TRANSLATIONAL$38,143
U54 · FY2013 · HD · contact PI
Molecular and Clinical Pharmacology of Retinopathy of Prematurity$771,498
U54 · FY2012 · HD · contact PI
ADMINISTRATIVE$196,033
U54 · FY2012 · HD · contact PI
Synergistic Pharmacologicjntervention for Prevention of ROP (SPIPROP STUDY)$152,104
U54 · FY2012 · HD · contact PI
NEONATAL TRANSLATIONAL$38,144
U54 · FY2012 · HD · contact PI
Molecular and Clinical Pharmacology of Retinopathy of Prematurity$806,622
U54 · FY2011 · HD · contact PI
ADMINISTRATIVE$227,926
U54 · FY2011 · HD · contact PI
Absorption and Metabolism of Oral Codeine in Mechanically Ventilated Neonates$96,744
R03 · FY2009 · HD · contact PI
Absorption and Metabolism of Oral Codeine in Mechanically Ventilated Neonates$96,971
R03 · FY2008 · HD · contact PI
Pediatric Pharmacology Research Unit$372,952
U10 · FY2006 · HD · contact PI
Pediatric Pharmacology Research Unit$375,680
U10 · FY2005 · HD
Pediatric Pharmacology Research Unit$364,640
U10 · FY2004 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$269,231
U01 · FY2003 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$261,678
U01 · FY2002 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$180,000
U01 · FY2002 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$180,000
U01 · FY2002 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$251,443
U01 · FY2001 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$282,009
U01 · FY2000 · HD